The Effect of HMG-CoA Reductase Inhibitor on Insulin Resistance in Patients Undergoing Peritoneal Dialysis

被引：0
|
作者：
Fa Mee Doh
Tae-Ik Chang
Hyang Mo Koo
Mi Jung Lee
Dong Ho Shin
Chan Ho Kim
Kwang Il Ko
Hyung Jung Oh
Tae-Hyun Yoo
Shin-Wook Kang
Dae-Suk Han
Seung Hyeok Han
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] NHIC Ilsan Hospital,Division of Nephrology
[3] Yonsei University,Brain Korea 21 for Medical Science, Severance Biomedical Science Institute
来源：
Cardiovascular Drugs and Therapy | 2012年 / 26卷
关键词：
HMG-CoA reductase inhibitor; Insulin resistance; Peritoneal dialysis; Adipokine; Chronic inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 509
页数：8
相关论文
共 50 条
  • [31] Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect
    Vincent, L
    Chen, W
    Hong, L
    Mirshahi, F
    Mishal, Z
    Mirshahi-Khorassani, T
    Vannier, JP
    Soria, J
    Soria, C
    FEBS LETTERS, 2001, 495 (03) : 159 - 166
  • [32] Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits
    Kato, M
    Sada, T
    Mizuno, M
    Kitayama, K
    Inaba, T
    Koike, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 556 - 562
  • [33] GENETIC-DETERMINANTS OF RESPONSIVENESS TO THE HMG-COA REDUCTASE INHIBITOR FLUVASTATIN IN PATIENTS WITH MOLECULARLY DEFINED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LEITERSDORF, E
    EISENBERG, S
    ELIAV, O
    FRIEDLANDER, Y
    BERKMAN, N
    DANN, EJ
    LANDSBERGER, D
    SEHAYEK, E
    MEINER, V
    WURM, M
    BARD, JM
    FRUCHART, JC
    STEIN, Y
    CIRCULATION, 1993, 87 (04) : 35 - 44
  • [34] Hyperleptinaemia, insulin resistance and survival in peritoneal dialysis patients
    Cao, Liou
    Mou, Shan
    Fang, Wei
    Gu, Leyi
    Huang, Jiaying
    Gu, Aiping
    Qian, Jiaqi
    Ni, Zhaohui
    NEPHROLOGY, 2015, 20 (09) : 617 - 624
  • [35] Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis
    Hasuike, Yukiko
    Moriguchi, Rintarou
    Hata, Reiko
    Miyagawa, Kouji
    Kuragano, Takahiro
    Aizawa, Masayo
    Yamamoto, Shigeo
    Yanase, Kimihiko
    Izumi, Masaaki
    Tanimoto, Tsuyoshi
    Nakanishi, Takeshi
    AMERICAN JOURNAL OF NEPHROLOGY, 2007, 27 (06) : 622 - 629
  • [36] Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction
    Wang, Hye Jin
    Park, Jae Yeo
    Kwon, Obin
    Choe, Eun Yeong
    Kim, Chul Hoon
    Hur, Kyu Yeon
    Lee, Myung-Shik
    Yun, Mijin
    Cha, Bong Soo
    Kim, Young-Bum
    Lee, Hyangkyu
    Kang, Eun Seok
    AUTOPHAGY, 2015, 11 (11) : 2089 - 2101
  • [37] Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis
    Ito, S
    Kuwabara, S
    Sakakibara, R
    Oki, T
    Arai, H
    Oda, S
    Hattori, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 216 (01) : 179 - 182
  • [38] Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy
    Alvarez-Prats, Alejandro
    Hernandez-Perera, Octavio
    Diaz-Herrera, Pilar
    Ucero, Alvaro C.
    Anabitarte-Prieto, Aranzazu
    Losada-Cabrera, Antonio
    Ortiz, Alberto
    Rodriguez-Perez, Jose C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2720 - 2733
  • [39] Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits
    Takayama, Makoto
    Matsubara, Masahiro
    Arakawa, Emi
    Takada, Chie
    Ina, Yasuhiro
    Hasegawa, Kazuhide
    Yao, Kozo
    VASCULAR PHARMACOLOGY, 2007, 46 (04) : 302 - 308
  • [40] HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation
    Azuma, RW
    Suzuki, J
    Ogawa, M
    Futamatsu, H
    Koga, N
    Onai, Y
    Kosuge, H
    Isobe, M
    CARDIOVASCULAR RESEARCH, 2004, 64 (03) : 412 - 420
12345